Keel Point’s Rentokil RTO Stock Holding History

Keel Point’s Portfolio RTO Stock Details RTO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-6,588	Closed	-$203K	–	461
2024 Q2	$203K	Buy	+6,588	New	+$183K	0.02%	413
2023 Q4	–	Sell	-5,544	Closed	-$205K	–	360
2023 Q3	$205K	Buy	5,544 +18	+0.3%	+$688	0.03%	295
2023 Q2	$216K	Buy	5,526 +33	+0.6%	+$1.29K	0.03%	298
2023 Q1	$201K	Buy	+5,493	New	+$173K	0.03%	294

Other funds holding RTO

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

GCM

Gates Capital Management New York $3.66B AUM 12.63% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return

RRAM

River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Harvey Partners Tarrytown, New York $1.26B AUM 64.44% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Keel Point's RTO Position: Q3 2024 in Review

Keel Point sold out of Rentokil (RTO) in Q3 2024, closing a stake of 6,588 shares — an estimated $203K sold.

Keel Point first reported a position in RTO in Q1 2023 and held it in 4 quarters. The position peaked at $216K in Q2 2023. 220 funds tracked by Wall St. Rank hold RTO as of Q3 2024.

Keel Point reported no remaining Rentokil position as of Q3 2024 after selling out during the quarter.
Keel Point sold 6,588 Rentokil shares in Q3 2024, an estimated $203K.
Keel Point first reported a position in Rentokil in Q1 2023 and held it in 4 quarters.
Keel Point's Rentokil position peaked at $216K in Q2 2023.
220 funds tracked by Wall St. Rank held Rentokil as of Q3 2024.

Based on Keel Point's 13F filing for Q3 2024, filed 14 Nov 2024.